Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTRN12620001333909Phase 4Not yet recruiting
Phase 4, randomised, open-label trial of nicotine in nicotine dependence (2 arms), sponsored by University of Newcastle. Primary endpoint: Feasibility of research procedures. Planned start Jan 2021; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ACTRN12620001333909.